Beam Therapeutics Inc. (BEAM) - Risk-Adjusted Returns & Sharpe Ratio | pfolio
Beam Therapeutics Inc. (BEAM): 1Y return 101.8%, Sharpe ratio 1.29, volatility 72.1%, max drawdown -38.2%. A Stock in the Equity asset class. Compare BEAM with other assets and invest through your own broker with pfolio.
Beam Therapeutics Inc. (BEAM) Overview
- Type: Stock
- Asset Class: Equity
- Region: Americas
- Country: US (Developed)
- Currency: USD
BEAM Performance
- MTD
- Return: 8.6%, Sharpe: 1.76, Volatility: 69.0%, Max Drawdown: -18.6%
- YTD
- Return: 18.8%, Sharpe: 0.90, Volatility: 76.6%, Max Drawdown: -38.2%
- 1Y
- Return: 101.8%, Sharpe: 1.29, Volatility: 72.1%, Max Drawdown: -38.2%
- 5Y
- Return: -57.9%, Sharpe: 0.14, Volatility: 74.1%, Max Drawdown: -89.1%
Frequently Asked Questions
- What is Beam Therapeutics Inc. (BEAM)?
- Beam Therapeutics Inc. (BEAM) is a Stock in the Equity asset class. pfolio shows its cumulative return, volatility, Sharpe ratio, and max drawdown across MTD, YTD, 1Y, 5Y, 10Y, 20Y, and all-time periods.
- How does BEAM compare to other assets?
- You can compare BEAM with any other asset using pfolio's comparison tool, which ranks assets side-by-side by risk-adjusted returns.
- Can I invest in BEAM through pfolio?
- pfolio helps you build diversified portfolios that may include BEAM. You invest through your own broker — pfolio provides the analytics.